Source: Annual Congress 2005 - CPAP therapy
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
A. E. Taurino, C. Bruschi, R. Trentin, N. D‘D‘Artavilla Lupo, S. Montemartini, F. Fanfulla (Montescano, Italy). The reversibility of hypoxemia in OSA patients is related to CPAP therapy. Eur Respir J 2005; 26: Suppl. 49, 785

Member's Comments

No comment yet.

Related content which might interest you: The influence of long-term CPAP therapy on metabolic variables in obstructive sleep apnea patients Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018 Automatic bi-level positive airway pressure therapy in non compliant CPAP patients with obstructive sleep apnoea Source: Annual Congress 2007 - Sleep apnoea and adaptive servo–ventilation Year: 2007 Compliance for NIMV treatment in moderate and severe OSAS patients Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology Year: 2012 Persistent daytime hypercapnia predicts poor prognosis in OSAS undergoing CPAP therapy Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation Year: 2016 The effect of CPAP in asthma patients with SAHS Source: Virtual Congress 2021 – Home mechanical ventilation: organisation and outcomes Year: 2021 Efficacy of continuous positive airway pressure in treatment of patients with bradyarrhythmias associated with obstructive sleep apnoea syndrome Source: Annual Congress 2006 - Cardiovascular consequences of obstructive sleep apnoea Year: 2006 Compliance of positive airway pressure therapy in patients with sleep related breathing disorder Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy Year: 2008 CPAP setting prediction in OSAS patients Source: Annual Congress 2011 - Physiology and diagnostic technology in obstructive sleep apnoea Year: 2011 Treatment with CPAP reduces mortality in patients with obstructive sleep apnoea syndrome within less than 3 years Source: Annual Congress 2006 - Therapeutic effects in obstructive sleep apnoea Year: 2006 Predictors of compliance with CPAP in patients with OSA and metabolic syndrome Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea Year: 2009 Eficacy of the treatment with CPAP in patients with chronic heart failure and sleep apnoea Source: Eur Respir J 2004; 24: Suppl. 48, 564s Year: 2004 Daytime risk factors of nocturnal hyoxemia in COPD patients unqualified for long-term oxygen therapy Source: Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD Year: 2012 Hypercapnia and respiratory drive in obstructive sleep apnoea patients before and after CPAP treatment Source: Eur Respir J 2002; 20: Suppl. 38, 103s Year: 2002 Long-term outcome of nCPAP therapy in sleep apnoea patients Source: Eur Respir J 2004; 24: Suppl. 48, 569s Year: 2004 CPAP treatment reduce blood pressure in patients with recent diagnosis of systemic hypertension and obstructive sleep apnoea -hypopnoea (OSAH). A controlled study Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy Year: 2008 Daytime hypoxemia in obstructive sleep apnoea (OSA) subjects before CPAP therapy Source: Annual Congress 2009 - Clinical aspects of sleep apnoea Year: 2009 A study of insulin resistance in moderate to severe obstructive sleep apnea in non diabetics and its response to nasal CPAP treatment Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea Year: 2011 The effect of CPAP treatment on Galectin-3 level in patients with severe obstructive sleep apnea Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018 Effect of treatment with CPAP in patients with resistant hypertension and obstructive apneas Source: Eur Respir J 2005; 26: Suppl. 49, 113s Year: 2005 Cardiovascular regulation effects of CPAP therapy in obstructive sleep apnea patients with and without hypertension during daytime Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II Year: 2012